Rho (D) immune globulin
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
- Suppression of Rh isoimmunization in non-sensitized, Rh o (D)-negative women to reduce likelihood of hemolytic disease in Rh o (D)-positive fetus in present and future pregnancies.
- Treatment of ITP (including ITP secondary to HIV) in non-splenectomized, Rh o (D)-positive pts.
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
- Suppression of Rh isoimmunization in non-sensitized, Rh o (D)-negative women to reduce likelihood of hemolytic disease in Rh o (D)-positive fetus in present and future pregnancies.
- Treatment of ITP (including ITP secondary to HIV) in non-splenectomized, Rh o (D)-positive pts.
There's more to see -- the rest of this topic is available only to subscribers.